Follow The Filings

GUTS Fractyl Health Inc.

Health Care, filed as FRACTYL HEALTH INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $3.2M

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Lee Ainslie, Maverick Capital). Not free-float ownership.

  1. Lee Ainslie 0.03%

Who owns GUTS

Sorted by value, long equity only, as of 2026 Q2.

History
Lee Ainslie, Maverick Capital 0.03% Hold 3,974,806 $3.2M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GUTS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GUTS insider trades
  • $187K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. William Bradley Director
    Buy
    $40K 64,516 shares at $0.6200 +76% to stake
    Traded Sep 14 Filed Sep 16
    ↗
  2. Ajay Royan Director
    Buy
    $20K 23,000 shares at $0.8500 +129% to stake
    Traded Jun 12 Filed Jun 15
    ↗
  3. William Bradley Director
    Buy
    $50K 68,493 shares at $0.7300 +425% to stake
    Traded Jun 10 Filed Jun 11
    ↗
  4. Ian Sheffield Director
    Buy
    $26K 35,000 shares at $0.7300 New stake
    Traded Jun 10 Filed Jun 11
    ↗
  5. Harith Rajagopalan CEO
    Buy
    $18K 25,000 shares at $0.7300 +4.8% to stake
    Traded Jun 10 Filed Jun 11
    ↗
  6. Weber Lara Smith CFO
    Buy
    $14K 20,000 shares at $0.6900 New stake
    Traded Jun 8 Filed Jun 9
    ↗
  7. Harith Rajagopalan CEO
    Buy
    $20K 10,416 shares at $1.92 +2.1% to stake
    Traded Dec 4, 2025 Filed Dec 8, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.05,5.02,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 3.01 Filing Doc
DEF 14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 3.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $93,000 $0.00
Gross profit * $43,000 $0.00
Gross margin * 46.2% —
Net income -$68.69M -$140.95M
Net margin * -73864.5% —

Balance sheet

Metric FY2024 FY2025
Total current assets $71.76M $87.58M
Total non-current assets * $36.31M $33.83M
Total assets $108.08M $121.4M
Total current liabilities $19.78M $18.33M
Total non-current liabilities * $59.88M $93.62M
Total equity $28.42M $9.46M

Cash flow

Metric FY2024 FY2025
Cash from operations -$65.52M -$90.33M
Cash from investing -$1.76M -$0.557M
Cash from financing $101.23M $104.96M
Net change in cash $33.94M $14.08M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.